Acknowledgements & Disclosures


The American College of Rheumatology (ACR) is the leading authority and trusted partner of rheumatology professionals.

The ACR believes that collective efforts are essential to advance the quality of patient care and improve outcomes in rheumatology, and that it has mutual goals with external entities including corporations in the pharmaceutical, biotech, and medical device industries. These external entities advance innovation and contribute in meaningful ways to the rheumatology community.

The ACR regularly engages with these external entities in strategic relationships that affirm and support its mission and core values. When structured correctly, the ACR asserts that these relationships can be ethical, positive, and productive.

These strategic relationships are governed by the ACR Guiding Principles for Interactions with External Entities.

Corporate Supporters

The ACR engages in strategic, collaborative initiatives and works closely with external entities, including corporations, in areas of mutual interest that advance the field of rheumatology and add value to the community. The ACR believes these financial relationships should be transparent.

The American College of Rheumatology thanks our corporate supporters for their commitment to advancing rheumatology by supporting the activities of the ACR and ARP. It is through the generous support of our industry colleagues that we can successfully continue our work of providing programs of education, research, and practice support to the rheumatology community.

Thank You to Our Corporate Supporters

ACR Winter Rheumatology Symposium
The ACR thanks AbbVie, Inc. and UCB, Inc. for independent medical education grant support of the 2023 Winter Rheumatology Symposium.

ACR Education Exchange

  • State-of-the-Art Clinical Symposium
    The ACR thanks AbbVie, Inc., Pfizer, Inc., and Janssen Scientific Affairs, Inc., for their support of the 2022 State-of-the-Art Clinical Symposium.
  • The Training Rheum
    The ACR and ARP thank AbbVie, Inc., and Pfizer, Inc., for their support of The Training Rheum 2022.

ACR CARE Program
The ACR thanks AbbVie, Inc., and Bristol Myers Squibb Company for their support of CARE 2022.

ACR Convergence
Please check back soon for 2023 supporter disclosures.

We use cookies on our website to improve our service to you and for security purposes. By continuing to use our site without changing your browser cookie settings, you agree to our cookie policy and the use of cookies. See ACR Policies